鶹ýӰ

Meeting Coverage

CROI

Conference on Retroviruses and Opportunistic Infections

Dapivirine Vaginal Ring, Oral PrEP Safe for HIV Prevention in Pregnancy

Interventions needed to prevent a catastrophe in maternal and infant outcomes, says researcher

CROI over a photo of Colorado Convention Center in Denver, CO

Latest CROI Meeting Coverage

Novel Short-Duration TB Treatment Fizzles

Questionable efficacy, potential toxicity "tips the scales" against clofazimine-based regimen

March 11, 2024
Once-Weekly ART Showed Similar Efficacy for HIV as Daily ART

Virologic suppression rate was 94.2% in both groups

March 11, 2024
Triplet Regimen Shortens Effective TB Treatment

Three-drug combo over 4 months was comparable to standard treatment over 6 months

March 11, 2024
Monthly ART Injections Top Pills for HIV Patients With Adherence Problems

Trial halted early for efficacy despite not meeting significance criteria on primary endpoint

March 8, 2024
Semaglutide Cuts Liver Disease Severity in People With HIV

Weekly injections reduced liver fat by 31% at 6 months

March 8, 2024
Interventions Can Reduce CVD Risk Factors in HIV Patients, Studies Show

Lowering blood pressure, cholesterol prove feasible in randomized trials

March 7, 2024
Alpibectir-Ethionamide Safe for TB, With Similar Activity to Isoniazid

Fixed-dose combination shows promise in small trial

March 7, 2024
'Vampire Facials' at Spa Linked to HIV Infections

Unsanitary conditions resulted in infections in three people; investigation still ongoing

March 7, 2024
Semaglutide Reduced Inflammatory Biomarkers in HIV Patients With Lipohypertrophy

Levels of IL-6, high-sensitivity CRP, and soluble CD163 were decreased with the GLP-1 agonist

March 6, 2024
Steep Decline in Chlamydia, Syphilis Rates 'Seals the Case' for DoxyPEP

Other data showed high uptake of doxycycline post-exposure prophylaxis among PrEP users

March 5, 2024
Long-Acting Injectable Comparable to Oral ART for HIV in Sub-Saharan Africa

Trial is "essential first step" in exploring this public health strategy, researcher says

March 5, 2024
What Next After Early End of MOSAICO HIV Vaccine Trial?

Main focus now will be approaches using broadly neutralizing HIV-1 antibodies, researchers say

February 24, 2023
Remdesivir Finally Shows Mortality Benefit in Hospitalized COVID Patients

Antiviral should have been recommended sooner for non-ventilated patients, editorialist argues

February 23, 2023
Long-Acting Injectable HIV Regimen on Par With Daily Drugs

Trial shows noninferiority to daily antiretroviral pills for controlling HIV

February 23, 2023